首页> 外文会议>International Gastric Cancer Congress >Clinicopathological findings for adenocarcinoma of the esophagogastric junction
【24h】

Clinicopathological findings for adenocarcinoma of the esophagogastric junction

机译:食管胃部交界处的腺癌临床病理学发现

获取原文

摘要

The prognose for adenocarcinoma of the esophagogastric junction (AEG) is worse than that for other gastric carcinoma. Siewert et al. recommended the extended total gastrectomy for type II and type III tumors, and transhiatal esophagectomy for type I. We have experience with 40 AEG cases, in which no recurrence occurred at the stump of the esophagus. The 3-year surcical rates were 50%, 56.3%, 56.3%, and 32.1% for Stages I, IIA+IIB, III, and IV, respectively. These data indicate that, more intensive adjuvant chemotherapy might be beneficial for patients with relatively early stage disease, namely, Stages I, IIA and IIB.
机译:食管胃部结(AEG)腺癌的预测比其他胃癌的腺癌(AEG)更差。 Siewert等人。 推荐II型和III型肿瘤的延长总胃切除术,以及Transhiatal食管切除术,适用于I型。我们有40例AEG病例的经验,在食道的树桩中没有发生复发。 3年龄率分别为50%,56.3%,56.3%和32.1%,分别为阶段I,IIA + IIB,III和IV。 这些数据表明,更密集的辅助化疗对患有相对早期疾病的患者可能有益,即阶段I,IIA和IIB。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号